OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Sean Joseph

1 Projects | 1 Researchers | $3,000,000 Invested

2022

The Scripps Research Institute

Sean Joseph

Long Acting GM-CSF Fusion Protein (PDM608) for the Treatment of Alzheimer’s Disease

  • Funding Amount: $3,000,000
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Target: Neuroinflammation
  • Status: Closed